Advisory Services Network’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-274
| Closed | -$425 | – | 1913 |
|
|
2023
Q4 | $425 | Buy |
+274
| New | +$425 | ﹤0.01% | 3646 |
|
|
2023
Q2 | – | Sell |
-412
| Closed | -$622 | – | 1919 |
|
|
2023
Q1 | $622 | Hold |
412
| – | – | ﹤0.01% | 3705 |
|
|
2022
Q4 | $659 | Buy |
+412
| New | +$659 | ﹤0.01% | 3691 |
|
|
2021
Q3 | – | Sell |
-412
| Closed | -$3K | – | 1793 |
|
|
2021
Q2 | $3K | Buy |
+412
| New | +$3K | ﹤0.01% | 3201 |
|
|
2021
Q1 | – | Sell |
-412
| Closed | -$3K | – | 1688 |
|
|
2020
Q4 | $3K | Sell |
412
-4
| -1% | -$29 | ﹤0.01% | 2862 |
|
|
2020
Q3 | $3K | Buy |
+416
| New | +$3K | ﹤0.01% | 2930 |
|
|
2020
Q2 | – | Sell |
-412
| Closed | -$3K | – | 1372 |
|
|
2020
Q1 | $3K | Buy |
412
+274
| +199% | +$2K | ﹤0.01% | 2628 |
|
|
2019
Q4 | $1K | Buy |
+138
| New | +$1K | ﹤0.01% | 2929 |
|